Methods of sensitizing cancer to therapy-induced cytotoxicity

Details for Australian Patent Application No. 2006311734 (hide)

Owner The Regents of the University of California Nereus Pharmaceuticals

Inventors Palladino, Michael; Bonavida, Benjamin

Agent Davies Collison Cave

Pub. Number AU-A-2006311734

PCT Pub. Number WO2007/056335

Priority 60/733,965 04.11.05 US; 60/840,811 28.08.06 US

Filing date 6 November 2006

Wipo publication date 18 May 2007

International Classifications

A61K 31/409 (2006.01) - having four such rings, e.g. porphine derivatives, bilirubin, biliverdine

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/056335 Priority application(s): WO2007/056335

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311752-CD40 ligand fusion protein vaccine

2006311730-Compositions and methods for inhibiting expression of Factor V Leiden mutant gene